Douglas Fleming
About
In The Last Decade
Douglas Fleming
152 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 171
- Epidemiology 5.4k
- Infectious Diseases 1.4k
- Modeling and Simulation 807
- Pulmonary and Respiratory Medicine 799
- General Health Professions 751
Countries citing papers authored by Douglas Fleming
This map shows the geographic impact of Douglas Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Fleming more than expected).
Fields of papers citing papers by Douglas Fleming
This network shows the impact of papers produced by Douglas Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Fleming. The network helps show where Douglas Fleming may publish in the future.
Co-authorship network of co-authors of Douglas Fleming
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Fleming. A scholar is included among the top collaborators of Douglas Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Fleming. Douglas Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 17 | |
| 2 | Telotristat etiprate shows benefit in treating patients With carcinoid syndrome that is inadequately controlled by somatostatin analog therapy in the phase 3 TELESTAR clinical trial | 1 |
| 3 | 10 | |
| 4 | Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases. | 151 |
| 5 | 2 | |
| 6 | 3 | |
| 7 | 12 | |
| 8 | 90 | |
| 9 | The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. | 122 |
| 10 | The application of a general practice database to pharmaco epidemiology. Birmingham Morbidity and Prescribing Information Project. | 1 |
| 11 | Annual and seasonal variation in the incidence of common diseases. | 34 |
| 12 | Observations on the influenza epidemic of November/December 1989. | 16 |
| 13 | THE DUTCH SENTINEL PRACTICE NETWORK | 1 |
| 14 | Consultation rates in English general practice. | 14 |
| 15 | Diagnosis and patterns of incidence of influenza, influenza-like illness and the common cold in general practice. | 24 |
| 16 | Telephone advice in managing out-of-hours calls | 2 |
| 17 | A comparison of the practice activities of trainees and principals. | 14 |
| 18 | 27 | |
| 19 | 6 | |
| 20 | 31 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.